SCHEMBL8330101

SCHEMBL8330101

CC(C)(NC(=O)OCc1ccccc1)C(=O)N[C@@H]1CCc2ccccc2N(Cc2ccc(-c3ccccc3CNC(=O)NC3CC3)cc2)C1=O

nearest known ligand 0.66

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.66
XIAP P98170 6/20 0.48
NPY1R P25929 5/20 0.47
PTGER1 P34995 2/20 0.47
PTGER3 P43115 2/20 0.47
PTGER4 P35408 1/20 0.47
PTGER2 P43116 1/20 0.47
AGTR1 P30556 1/20 0.45
MME P08473 1/20 0.43
ACE P12821 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7785743 0.95 GHSR (0.69) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8331869 0.94 GHSR (0.76) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8330387 0.93 GHSR (0.76) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8330701 0.93 GHSR (0.67) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8330710 0.93 GHSR (0.76) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8329246 0.92 GHSR (0.69) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8333061 0.92 GHSR (0.65) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8326513 0.92 GHSR (0.66) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8331766 0.91 GHSR (0.63) GHSRXIAPNPY1RPTGER1PTGER3
SCHEMBL8328518 0.91 GHSR (0.66) GHSRXIAPNPY1RPTGER1PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US disclosed